MERCK & CO: SAFETY PROFILE OF INTISMERAN PLUS KEYTRUDA WAS GENERALLY CONSISTENT WITH PREVIOUSLY REPORTED STUDIES OF COMBINATION

Reuters · 3d ago

Please log in to view news